Ikaros family zinc finger 1 regulates dendritic cell development and function in humans

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Cytlak, Urszula ^a   Resteu, Anastasia ^a   Bogaert, Delfien ^b,c   Kuehn, Hye Sun ^d   Altmann, Thomas ^a,e   Gennery, Andrew ^a,e   Jackson, Graham ^a,e   Kumanovics, Attila ^f   Voelkerding, Karl V ^f   Prader, Seraina ^g   Dullaers, Melissa ^b,h   Reichenbach, Janine ^g,i   Hill, Harry ^f   Haerynck, Filomeen ^b   Rosenzweig, Sergio D ^d   Collin, Matthew ^a,e   Bigley, Venetia ^a,e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^h GHENT UNIVERSITY   (Belgium)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD123 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; IKAROS FAMILY ZINC FINGER 1; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 8; LENALIDOMIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; IKZF1 PROTEIN, HUMAN;

CELL; DEVELOPMENTAL BIOLOGY; GENE; GENE EXPRESSION; IMMUNE RESPONSE; MUTATION;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; STEM CELL; HAPLOINSUFFICIENCY; HEMATOPOIESIS; METABOLISM; PHYSIOLOGY;

MAMMALIA; MUS;

DENDRITIC CELLS; HAPLOINSUFFICIENCY; HEMATOPOIESIS; HUMANS; IKAROS TRANSCRIPTION FACTOR; INTERFERON-ALPHA; INTERLEUKIN-12; LENALIDOMIDE;

EID: 85044601524     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-02977-8     Document Type: Article

References (50)

1. Milner, J. D. & Holland, S. M. The cup runneth over: lessons from the everexpanding pool of primary immunodeficiency diseases. Nat. Rev. Immunol. 13, 635-648 (2013).
2. Collin, M., Bigley, V., Haniffa, M. & Hambleton, S. Human dendritic cell deficiency: the missing ID? Nat. Rev. Immunol. 11, 575-583 (2011).
3. Kapsenberg, M. L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3, 984-993 (2003).
4. Sapoznikov, A. et al. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat. Immunol. 9, 388-395 (2008).
5. Reboldi, A. et al. IgA production requires B cell interaction with subepithelial dendritic cells in Peyer's patches. Science 352, aaf4822 (2016).
6. Guimond, M. et al. In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J. Immunol. 184, 2769-2775 (2010).
7. Sallusto, F. et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29, 1617-1625 (1999).
8. Haniffa, M., Bigley, V. & Collin, M. Human mononuclear phagocyte system reunited. Semin. Cell Dev. Biol. 41, 59-69 (2015).
9. Swiecki, M. & Colonna, M. The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 15, 471-485 (2015).
10. Lauterbach, H. et al. Mouse CD8alpha+DCs and human BDCA3+DCs are major producers of IFN-lambda in response to poly IC. J. Exp. Med. 207, 2703-2717 (2010).
11. Nizzoli, G. et al. Human CD1c+dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 122, 932-942 (2013).
12. Murphy, T. L. et al. Transcriptional control of dendritic cell development. Annu. Rev. Immunol. 34, 93-119 (2016).
13. Dickinson, R. E. et al. The evolution of cellular deficiency in GATA2 mutation. Blood 123, 863-874 (2014).
14. Cisse, B. et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135, 37-48 (2008).
15. Jaiswal, H. et al. Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8alpha+dendritic cell development. J. Immunol. 191, 5993-6001 (2013).
16. Hambleton, S. et al. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365, 127-138 (2011).
17. Sichien, D. et al. IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively. Immunity 45, 626-640 (2016).
18. Schlitzer, A. et al. IRF4 transcription factor-dependent CD11b+dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970-983 (2013).
19. Feinberg, M. W. et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 26, 4138-4148 (2007).
20. Patel, A. A. et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J. Exp. Med. 214, 1913-1923 (2017).
21. Merkenschlager, M. Ikaros in immune receptor signaling, lymphocyte differentiation, and function. FEBS Lett. 584, 4910-4914 (2010).
22. Allman, D. et al. Ikaros is required for plasmacytoid dendritic cell differentiation. Blood 108, 4025-4034 (2006).
23. Wu, L., Nichogiannopoulou, A., Shortman, K. & Georgopoulos, K. Cellautonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7, 483-492 (1997).
24. Lucioni, M. et al. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood 118, 4591-4594 (2011).
25. Kuehn, H. S. et al. Loss of B cells in patients with heterozygous mutations in IKAROS. N. Engl. J. Med. 374, 1032-1043 (2016).
26. Hoshino, A. et al. Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations. J. Allergy Clin. Immunol. 140, 223-231 (2016).
27. Bogaert, D. J. et al. A novel IKAROS haploinsufficiency kindred with unexpectedly late and variable B-cell maturation defects. J. Allergy Clin. Immunol. 141, 432-435.e7 (2017).
28. Krönke, J. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301-305 (2014).
29. Lu, G. et al. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343, 305-309 (2014).
30. Van Gassen, S. et al. FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A 87, 636-645 (2015).
31. European Medicines Agency. Assessment Report, Revlimid. Report No. EMEA/H/C/000717/II/0056 (European Medicines Agency, 2013).
32. Abdulhay, N. et al. Normal hematologic parameters and fetal hemoglobin silencing with heterozygous IKZF1 mutations. Blood 128, 2100-2103 (2016).
33. Rouillard, A. D. et al. The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford) http://amp.pharm.mssm.edu/Harmonizome/terms (2016).
34. Siedlar, M. et al. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++monocytes in common variable immunodeficiency (CVID) patients. Clin. Immunol. 139, 122-132 (2011).
35. Gamrekelashvili, J. et al. Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. Nat. Commun. 7, 12597 (2016).
36. Witkowski, M. T. et al. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia. Leukemia 29, 1301-1311 (2015).
37. Gopalakrishnan, R., Matta, H., Tolani, B., Triche, T. & Chaudhary, P. M. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors. Oncogene 35, 1797-1810 (2016).
38. Vo, M. C. et al. Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma. Exp. Hematol. 46, 48-55 (2017).
39. Costa, F. et al. Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties. Oncotarget 8, 53053-53067 (2017).
40. Movassagh, M., Laderach, D. & Galy, A. Proteins of the Ikaros family control dendritic cell maturation required to induce optimal Th1 T cell differentiation. Int. Immunol. 16, 867-875 (2004).
41. Sung, M. H. et al. Switching of the relative dominance between feedback mechanisms in lipopolysaccharide-induced NF-κB signaling. Sci. Signal. 7, ra6 (2014).
42. Baillie, J. K. et al. Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease. PLoS Genet. 13, e1006641 (2017).
43. Gautier, G. et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 201, 1435-1446 (2005).
44. Crother, T. R. et al. Plasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in mice. PLoS ONE 7, e48655 (2012).
45. Poeck, H. et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103, 3058-3064 (2004).
46. Matta, B. M., Castellaneta, A. & Thomson, A. W. Tolerogenic plasmacytoid DC. Eur. J. Immunol. 40, 2667-2676 (2010).
47. Chauhan, D. et al. Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell 16, 309-323 (2009).
48. Nguyen-Pham, T. N. et al. Lenalidomide synergistically enhances the effect of dendritic cell vaccination in a model of murine multiple myeloma. J. Immunother. 38, 330-339 (2015).
49. Noonan, K. et al. Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses. Clin. Cancer Res. 18, 1426-1434 (2012).
50. Kim, J. M., Park, S. H., Kim, H. Y. & Kwok, S. K. A plasmacytoid dendritic cells-type I interferon axis is critically implicated in the pathogenesis of systemic lupus erythematosus. Int J. Mol. Sci. 16, 14158-14170 (2015).